For example, overexpression of PAD2 has been shown to augment the malignancy of skin tumors (153), while increased PAD2 expression has been linked to improved survival in patients with estrogen receptor (ER)-positive breast cancer (112). Here, PADI2 is linked to breast carcinoma.